The Government of Australia has signed a 10-year partnership agreement with the Government of Moderna and the State Government of Victoria to produce the mRNA COVID-19 vaccine and other mRNA vaccines in the state.
“This is an Australian attack by Australians to protect them from future pandemics and secure new manufacturing capacity on our coast,” Scott Morrison said on March 24.
$ 1.5 billion ($ 1.12 million) Moderna manufacturing strategy Australia plans to inoculate up to 100 million mRNAs annually to protect against new COVID-19 strains and new respiratory illnesses.
Under the agreement, Australia, along with other respiratory viruses, is expected to obtain a long-term guaranteed vaccine supply, as well as COVID-19, influenza, and COVID-19 vaccine options with influenza.
The mRNA production facility is one of the first facilities in the world and the first in the Southern Hemisphere.
The construction of the facility is expected to support 500 direct jobs, hundreds of indirect jobs will be supported, and when the hub goes live from 2024, up to 200 highly skilled staff will work in the facility. Is expected.
Federal Health Minister Greg Hunt said the partnership is “important insurance” for national health and means that Australians will have access to “state-of-the-art vaccination technology available.”
Treasury Minister Simon Birmingham said the deal would enhance Australia’s future prosperity as Moderna will be a key player in the development of Australia’s RNA technology.
The news of this agreement came first December 14th2021, when the federal government announced the Principle Agreement with Victoria and Moderna.
At that time, Victoria’s Treasury Minister Tim Pallas Said: “This will benefit both the economic recovery and the fight against future pandemics.”
The Australian Government has promised an additional investment of $ 25 million between 2022 and 23. 2021 mRNA clinical trials that enable infrastructure opportunities Promote the development of national mRNA technology.
Victoria too Announcement of agreement On March 18th, we increased “opportunities for global collaboration with Victorian researchers and industry” among government agencies, mRNA Victoria and Pfizer.
Vaccine production is expected to begin in 2024, awaiting regulatory and plan approval.